{"id":"https://openalex.org/W2005196429","doi":"https://doi.org/10.1002/(sici)1097-0215(19960917)67:6<864::aid-ijc17>3.0.co;2-1","title":"Interaction of interleukin-11 with cytotoxic therapiesin vitro against CEM cells andin vivo against EMT-6 murine mammary carcinoma","display_name":"Interaction of interleukin-11 with cytotoxic therapiesin vitro against CEM cells andin vivo against EMT-6 murine mammary carcinoma","publication_year":1996,"publication_date":"1996-09-17","ids":{"openalex":"https://openalex.org/W2005196429","doi":"https://doi.org/10.1002/(sici)1097-0215(19960917)67:6<864::aid-ijc17>3.0.co;2-1","mag":"2005196429","pmid":"https://pubmed.ncbi.nlm.nih.gov/8824560"},"language":"en","primary_location":{"id":"doi:10.1002/(sici)1097-0215(19960917)67:6<864::aid-ijc17>3.0.co;2-1","doi":"https://doi.org/10.1002/(sici)1097-0215(19960917)67:6<864::aid-ijc17>3.0.co;2-1","is_oa":true,"landing_page_url":"https://doi.org/10.1002/(sici)1097-0215(19960917)67:6<864::aid-ijc17>3.0.co;2-1","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/%28SICI%291097-0215%2819960917%2967%3A6%3C864%3A%3AAID-IJC17%3E3.0.CO%3B2-1","source":{"id":"https://openalex.org/S5382288","display_name":"International Journal of Cancer","issn_l":"0020-7136","issn":["0020-7136","1097-0215"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/%28SICI%291097-0215%2819960917%2967%3A6%3C864%3A%3AAID-IJC17%3E3.0.CO%3B2-1","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111548271","display_name":"Beverly A. Teicher","orcid":"https://orcid.org/0000-0003-1535-7304","observed_orcids":["https://orcid.org/0000-0003-1535-7304"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Beverly A. Teicher","raw_affiliation_strings":["Dana-Farber Cancer Institute and Joint Center for Radiation Therapy, Boston, USA","Dana\u2010Farber Cancer Institute and Joint Center for Radiation Therapy, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute and Joint Center for Radiation Therapy, Boston, USA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana\u2010Farber Cancer Institute and Joint Center for Radiation Therapy, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037699704","display_name":"Yingnan Chen","orcid":"https://orcid.org/0000-0002-0095-6040","observed_orcids":["https://orcid.org/0000-0002-0095-6040"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ying-nan Chen","raw_affiliation_strings":["Dana-Farber Cancer Institute and Joint Center for Radiation Therapy, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute and Joint Center for Radiation Therapy, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111601855","display_name":"Gulshan Ara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gulshan Ara","raw_affiliation_strings":["Dana-Farber Cancer Institute and Joint Center for Radiation Therapy, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute and Joint Center for Radiation Therapy, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067072266","display_name":"Yasunori Emi","orcid":"https://orcid.org/0000-0002-0364-8123","observed_orcids":["https://orcid.org/0000-0002-0364-8123"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yasunori Emi","raw_affiliation_strings":["Dana-Farber Cancer Institute and Joint Center for Radiation Therapy, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute and Joint Center for Radiation Therapy, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109207111","display_name":"Yoshihiro Kakeji","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yoshihiro Kakeji","raw_affiliation_strings":["Dana-Farber Cancer Institute and Joint Center for Radiation Therapy, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute and Joint Center for Radiation Therapy, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113653511","display_name":"Yoshihiko Maehara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yoshihiko Maehara","raw_affiliation_strings":["Dana-Farber Cancer Institute and Joint Center for Radiation Therapy, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute and Joint Center for Radiation Therapy, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Susan Keyes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan Keyes","raw_affiliation_strings":["Dana-Farber Cancer Institute and Joint Center for Radiation Therapy, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute and Joint Center for Radiation Therapy, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048597664","display_name":"David Northey","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Northey","raw_affiliation_strings":["Dana-Farber Cancer Institute and Joint Center for Radiation Therapy, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute and Joint Center for Radiation Therapy, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5111548271"],"corresponding_institution_ids":["https://openalex.org/I4210117453"],"apc_list":{"value":5030,"currency":"USD","value_usd":5030},"apc_paid":null,"fwci":0.2737,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.53311424,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"67","issue":"6","first_page":"864","last_page":"870"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.17499999701976776,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.17499999701976776,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.1421000063419342,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.11339999735355377,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interleukin-11","display_name":"interleukin-11","score":0.9980000257492065},{"id":"https://openalex.org/keywords/hematopoietic-growth-factors","display_name":"hematopoietic growth factors","score":0.7300000190734863},{"id":"https://openalex.org/keywords/chemotherapy-induced-myelosuppression","display_name":"chemotherapy-induced myelosuppression","score":0.6349999904632568},{"id":"https://openalex.org/keywords/melphalan","display_name":"melphalan","score":0.7009999752044678},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.875},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.8019999861717224},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.8970000147819519},{"id":"https://openalex.org/keywords/cytarabine","display_name":"cytarabine","score":0.859000027179718},{"id":"https://openalex.org/keywords/high-dose-chemotherapy","display_name":"high-dose chemotherapy","score":0.7200000286102295},{"id":"https://openalex.org/keywords/bone-marrow-recovery","display_name":"bone marrow recovery","score":0.7279999852180481},{"id":"https://openalex.org/keywords/granulocyte-colony-stimulating-factor","display_name":"granulocyte colony-stimulating factor","score":0.8690000176429749},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.7799999713897705}],"concepts":[{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.7271862626075745},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.6026598215103149},{"id":"https://openalex.org/C2778684742","wikidata":"https://www.wikidata.org/wiki/Q2298283","display_name":"Melphalan","level":3,"score":0.6014737486839294},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5826900005340576},{"id":"https://openalex.org/C2779968505","wikidata":"https://www.wikidata.org/wiki/Q416507","display_name":"ThioTEPA","level":4,"score":0.5751257538795471},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5465214252471924},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.5275782346725464},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.48515161871910095},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.44618740677833557},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.44085007905960083},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.36882054805755615},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3304353356361389},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3111538887023926},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2493044137954712},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.2005137801170349},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001853","descriptor_name":"Bone Marrow","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003114","descriptor_name":"Colony-Forming Units Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008325","descriptor_name":"Mammary Neoplasms, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008325","descriptor_name":"Mammary Neoplasms, Experimental","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":false},{"descriptor_ui":"D008325","descriptor_name":"Mammary Neoplasms, Experimental","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017370","descriptor_name":"Interleukin-11","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018906","descriptor_name":"Antineoplastic Agents, Alkylating","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":false},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1002/(sici)1097-0215(19960917)67:6<864::aid-ijc17>3.0.co;2-1","doi":"https://doi.org/10.1002/(sici)1097-0215(19960917)67:6<864::aid-ijc17>3.0.co;2-1","is_oa":true,"landing_page_url":"https://doi.org/10.1002/(sici)1097-0215(19960917)67:6<864::aid-ijc17>3.0.co;2-1","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/%28SICI%291097-0215%2819960917%2967%3A6%3C864%3A%3AAID-IJC17%3E3.0.CO%3B2-1","source":{"id":"https://openalex.org/S5382288","display_name":"International Journal of Cancer","issn_l":"0020-7136","issn":["0020-7136","1097-0215"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Cancer","raw_type":"journal-article"},{"id":"doi:10.1002/(sici)1097-0215(19960917)67:6<864::aid-ijc17>3.3.co;2-2","doi":"https://doi.org/10.1002/(sici)1097-0215(19960917)67:6<864::aid-ijc17>3.3.co;2-2","is_oa":false,"landing_page_url":"https://doi.org/10.1002/(sici)1097-0215(19960917)67:6<864::aid-ijc17>3.3.co;2-2","pdf_url":null,"source":{"id":"https://openalex.org/S5382288","display_name":"International Journal of Cancer","issn_l":"0020-7136","issn":["0020-7136","1097-0215"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Cancer","raw_type":"journal-article"},{"id":"pmid:8824560","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8824560","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of cancer","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1002/(sici)1097-0215(19960917)67:6<864::aid-ijc17>3.0.co;2-1","doi":"https://doi.org/10.1002/(sici)1097-0215(19960917)67:6<864::aid-ijc17>3.0.co;2-1","is_oa":true,"landing_page_url":"https://doi.org/10.1002/(sici)1097-0215(19960917)67:6<864::aid-ijc17>3.0.co;2-1","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/%28SICI%291097-0215%2819960917%2967%3A6%3C864%3A%3AAID-IJC17%3E3.0.CO%3B2-1","source":{"id":"https://openalex.org/S5382288","display_name":"International Journal of Cancer","issn_l":"0020-7136","issn":["0020-7136","1097-0215"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Journal of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8399999737739563,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2005196429.pdf","grobid_xml":"https://content.openalex.org/works/W2005196429.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W280510079","https://openalex.org/W325698903","https://openalex.org/W980161983","https://openalex.org/W1485182117","https://openalex.org/W1527138206","https://openalex.org/W1608210758","https://openalex.org/W1975045405","https://openalex.org/W1985520866","https://openalex.org/W2006416369","https://openalex.org/W2020636136","https://openalex.org/W2025955497","https://openalex.org/W2105853341","https://openalex.org/W2109012799","https://openalex.org/W2140403987","https://openalex.org/W2141889200","https://openalex.org/W2159203898","https://openalex.org/W2198695259","https://openalex.org/W2298463596","https://openalex.org/W2329535558","https://openalex.org/W2397277656","https://openalex.org/W2404888684","https://openalex.org/W2407640090","https://openalex.org/W2411459213","https://openalex.org/W2416711090","https://openalex.org/W2462473730","https://openalex.org/W2473335180","https://openalex.org/W2475202947","https://openalex.org/W4321428327","https://openalex.org/W6813740902"],"related_works":["https://openalex.org/W2071908042","https://openalex.org/W2389304628","https://openalex.org/W325698903","https://openalex.org/W2071967515","https://openalex.org/W2260013429","https://openalex.org/W1978373944","https://openalex.org/W2075487630","https://openalex.org/W2368996051","https://openalex.org/W2041802622","https://openalex.org/W2368855425"],"abstract_inverted_index":{"Interleukin-11(rhIL-11)":[0],"is":[1],"a":[2,166,203],"cytokine":[3],"that":[4],"has":[5],"been":[6],"shown":[7],"to":[8,53,61,112,152,187],"enhance":[9],"the":[10,31,36,46,69,76,88,95,101,114,125,189,195,214],"recovery":[11,206],"of":[12,33,38,58,71,78,90,98,116,144,207],"bone":[13,130],"marrow":[14,131],"and":[15,44,82,86,92,113,181,211],"intestinal":[16],"crypt":[17],"cells":[18,43,60,177,210],"after":[19],"cytotoxic":[20,54,117],"insult":[21],"with":[22,104,219,226],"radiation":[23],"or":[24,73,129,141,163],"anticancer":[25,55],"drugs.":[26,196],"The":[27],"current":[28],"study":[29],"examined":[30],"effects":[32],"rhIL-11":[34,62,105,145,198,220],"on":[35,45,149,169,178,183],"response":[37],"CEM":[39,59],"human":[40],"lymphoblastic":[41],"leukemia":[42],"EMT-6":[47,102,153],"murine":[48],"mammary":[49],"carcinoma":[50],"in":[51,120,124,202,213],"vivo":[52],"therapies.":[56],"Exposure":[57],"for":[63,108],"24":[64],"hr":[65],"did":[66],"not":[67],"alter":[68],"cytotoxicity":[70,77,89],"melphalan":[72],"radiation,":[74,139],"increased":[75],"CDDP":[79],"(100":[80],"muM)":[81],"4-hydroperoxycyclophosphamide":[83],"(50":[84],"betaM)":[85],"decreased":[87],"5-fluorouracil":[91,140],"ara-C":[93],"toward":[94],"cells.":[96],"Treatment":[97],"mice":[99],"bearing":[100,155],"tumor":[103,126,154,190],"twice":[106,146],"daily":[107],"4":[109],"days":[110,150,184],"prior":[111],"day":[115,148,170,179],"therapy":[118],"resulted":[119,201],"no":[121],"significant":[122],"change":[123],"cell":[127],"killing":[128,133],"CFU-GM":[132],"by":[134,173,194],"melphalan,":[135],"cyclophosphamide,":[136],"thiotepa,":[137],"CDDP,":[138],"ara-C.":[142],"Administration":[143],"per":[147],"7-18":[151],"animals":[156,217,227],"receiving":[157,228],"high":[158],"dose":[159,168],"chemotherapy":[160],"(melphalan,":[161],"thiotepa":[162],"cyclophosphamide)":[164],"as":[165],"single":[167],"7":[171],"followed":[172],"mobilized":[174],"peripheral":[175],"blood":[176,209],"8":[180],"rhG-CSF":[182],"8-20,":[185],"tended":[186],"prolong":[188],"growth":[191],"delay":[192],"produced":[193],"This":[197],"treatment":[199],"also":[200],"more":[204],"rapid":[205],"white":[208],"granulocytes":[212],"animals.":[215],"Furthermore,":[216],"treated":[218],"had":[221],"improved":[222],"survival":[223],"rates":[224],"compared":[225],"all":[229],"other":[230],"normal":[231],"tissue":[232],"support":[233],"without":[234],"rhIL-11.":[235]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}